2025 annual financial data
Seres Therapeutics 2025 Net margin
Direct answer
Net margin was 721.93%.
Operating income was -93.97M USD and net income was 5.7M USD.
Operating cash flow was 1.12M USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 789,000 USD
- Operating income
- -93.97M USD
- Net income
- 5.7M USD
- Operating cash flow
- 1.12M USD